"Exciting News!! The Cataract and Glaucoma Center, Dr. Louis Alpern, and Dr. Lawrence Tafoya are now part of the Southwest Eye Institute! Drs. Alpern and Tafoya are seeing patients with the same team at the same locations. To schedule an appointment, you can call them directly at (915) 267-2020 Dr. Alpern founded the Cataract and Glaucoma Center in 1978 and has been at the forefront of technological solutions in eye care since then. Dr. Lawrence Tafoya joined Dr. Alpern in 2017. They became an affiliate of the Southwest Eye Institute, the area’s most comprehensive eye group, in October of 2020."

During the past decade, Cataract & Glaucoma Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 11 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cataract & Glaucoma Center" #1 sponsor was "Aerie Pharmaceuticals" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "Santen Inc." with 2 trials sponsored and "Formosa Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cataract & Glaucoma Center" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cataract & Glaucoma Center" are "Ocular Hypertension" (6 trials), "Glaucoma" (3 trials), "Presbyopia" (3 trials), "Keratoconjunctivitis Sicca" (2 trials) and "Open Angle Glaucoma" (2 trials). Many other conditions were trialed in "Cataract & Glaucoma Center" in a lesser frequency.

Most popular intervention types in "Cataract & Glaucoma Center" are "Drug" (16 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGN-190584 ophthalmic solution" (2 trials), "AGN-199201 ophthalmic solution" (2 trials), "0.004% Travoprost" (1 trials), "0.25% AR-12286 / 0.004% travoprost" (1 trials) and "0.5% AR-12286, 0.004% travoprost" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cataract & Glaucoma Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Cataract & Glaucoma Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cataract & Glaucoma Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cataract & Glaucoma Center, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".